Risk Classification for Overall Survival by the Neutrophil–Lymphocyte Ratio and the Number of Metastatic Sites in Patients Treated with Pembrolizumab—A Multicenter Collaborative Study in Japan
暂无分享,去创建一个
S. Egawa | Tomohito Tanaka | H. Uehara | K. Takahara | T. Matsunaga | H. Azuma | K. Komura | T. Inamoto | Kohei Taniguchi | H. Nomi | R. Maenosono | Keita Nakamori | W. Fukuokaya | T. Kimura | T. Tsujino | Yuki Yoshikawa | T. Uchimoto | H. Hirano | Kazuki Nishimura | T. Tsutsumi | Yusuke Yano | Y. Fujiwara | Kazuhiro Takahashi